Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Tetherex closes $50mm Series B round

Executive Summary

Tetherex Pharmaceuticals Inc. (developing treatments for inflammatory diseases, thrombosis, and cancer) raised $50mm through its Series B round from investors including MPM Capital (lead) and a group of Oklahoma-based buyers. According to a Form D, a total of 240 investors participated.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Large Molecule
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies